Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZOSTER-060: Long-term Follow-up and Re-vaccination of HZ/su Vaccine in Adults 60+
NCT02735915Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2016
- Primary completion
- Aug 2017
- Countries
- 3
01
Overview
A Phase 3 trial of herpes zoster vaccine (recombinant, adjuvanted) in herpes zoster (HZ), sponsored by GSK. Started Apr 2016; status: completed.
02
Drugs
herpes zoster vaccine (recombinant, adjuvanted)
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT02735915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02735915.